Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Alcon Inc. Investors

Alcon Reports Third Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Reports Second Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Reports First Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Announces Results of 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Publishes Agenda for 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Host 2023 Capital Markets Day
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Reports Fourth Quarter and Full Year 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Prices US$1.3 Billion Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
From Alcon Inc. Investors
Via Business Wire
Tickers AERI ALC
Alcon Reports Third Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers AERI ALC
Alcon Reports Second Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Prices EUR 500.0 Million Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Reports First Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Announces Results of 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Deliver Robust Scientific Program at ASCRS 2022
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Publishes Agenda for 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Reports Fourth Quarter and Full Year 2021 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.